Senators urge rejection of PMI reduced risk application after TPSAC findings

Ten US Senators have urged the FDA to reject PMI's reduced risk application for IQOS following the findings of the independent Tobacco Products Scientific Advisory Committee (TPSAC) ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik